Tag: ESMO 2026

Health

Roche ESMO 2026 Guide: Lung, Breast Cancer Data in Madrid

The Swiss drugmaker will show late-stage results for three experimental cancer treatments at Europe’s biggest oncology meeting. The full data has not yet been published, and the claims so far come from the company itself. Roche ESMO 2026 plans were announced on Monday, October 19, 2026, when the company said it will present new late-stage trial results at the European Society for Medical Oncology (ESMO) Annual Meeting. The congress runs from October 23 to 27 in Madrid and includes two late-breaking abstracts from Roche, covering lung cancer, breast cancer and several hard-to-treat tumours. Because the meeting has not yet begun, the detailed figures have not been shown, and what is known comes from Roche’s announcement and early reporting of it. Roche ESMO 2026: the lung cancer result...
Toggle Dark Mode